Workshop_meeting in a room.jpg

News and Events 

Some of the things we have been up to

 

June 11-14, 2022

INTERVENE at ESHG 2022

The Annual Meeting of the European Society for Human Genetics was held in hybrid format in Vienna, Austria on June 11-14, 2022.


INTERVENE was strongly represented during the meeting, presenting posters and talks on ongoing work covering the application of polygenic scores for risk assessment and disease progression, as well as a new powerful approach for synthetic data generation.

Many thanks to our presenters:

  • Sophie Wharrie (Aalto University):  A fast method to generate hundreds of thousands of synthetic genomes and phenotypes (poster)

  • Brooke Walford (Norwegian University of Science and Technology): Effect of sex and age on disease prediction with polygenic scores in INTERVENE

  • Julian Wanner (Hasso Plattner Institute): Polygenic risk scores for disease progression in clinically related events         

  • Bradley Jermy (Institute for Molecular Medicine Finland, University of Helsinki): INTERVENE: exploring the generalizability of polygenic risk scores on disease

June 11, 2022

INTERVENE's Andrea Ganna awarded the 2022 Leena Peltonen Prize

We are happy and proud to announce that Andrea Ganna, FIMM-EMBL group leader and co-coordinator of INTERVENE, has received this year's Leena Peltonen prize at the ESHG annual meeting Vienna. Many congratulations, Andrea!

April 13-14, 2022

Berlin workshop

After nearly two years of COVID-imposed remote work, INTERVENE analysts finally got together for a face-to-face meeting from 13-14 April 2022 in Berlin, Germany. A group of international analysts and representatives from organisations in the project attended the two-day workshop.

February 16, 2022

A review of year 1

In early 2022, INTERVENE underwent a comprehensive scheduled evaluation by the European Commission to examine all project activities so far.

November 3, 2021

INTERVENE Annual Meeting

On November 2, 2021 we held the first INTERVENE Annual Meeting, uniting the entire INTERVENE consortium for a collegial day of discussion of performed and ongoing work, and to plan the execution of forward steps. Due to COVID-19 restrictions, the meeting was held virtually.

September 13, 2021

INTERVENE Newsletter

Check out the first newsletter from INTERVENE

June 9, 2021

Ranking the risk of heart disease

Samuli Ripatti appeared in the Nature Outlook discussing his work to identify individuals at high risk of coronary heart disease

February 9, 2021

INTERVENE featured on Genomeweb

News piece on INTERVENE on Genomeweb

January 18, 2021

INTERVENE launched!

We are all set to go! Check out the press release on the launch of INTERVENE